Titan Medical Inc (TMDIF)

[Endofanera]

What is the likelyhood that enough warrants to achieve this are owned by institutional investors that are also invested through other means in the company? I am not that familiar with previous warrant scenarios in other companies, but these institutional warrants alone could raise further money thus avoiding dilution regardless if in or out of the money. Guess it would depend on the "opportunity cost" of exercising potential out of the money warrants vs. getting hit with dilution; this break even may be so minor. Perhaps off the cuff talks between management and investors around this scenario. Just thinking creatively as the company has not raised that much to provide a runway. They must have something planned to achieve additional money through PPS increase/warrant exercising instead of another round of financing.

Being in the US and warrants owned by SCHWAB there is no point in me exercising as the shares will have a US restriction. Hopefully this can be figured out by the brokerage.